Cargando…

Leg‐type form of idiopathic multicentric Castleman disease associated with severe lower extremity chronic venous/lymphatic disease

Idiopathic multicentric Castleman disease (iMCD) is a lymphoproliferative disease of unknown etiology. Deciphering mechanisms involved in CD pathogenesis may help improving patients’ care. Six cases of stereotyped sub‐diaphragmatic iMCD affecting lower limb‐draining areas and associated with severe...

Descripción completa

Detalles Bibliográficos
Autores principales: Ballul, Thomas, Belfeki, Nabil, de Masson, Adèle, Meignin, Véronique, Woerther, Paul‐Louis, Martin, Antoine, Poullot, Elsa, Wargnier, Alain, Fadlallah, Jehane, Garzaro, Margaux, Malphettes, Marion, Fieschi, Claire, Maisonobe, Lucas, Bensekhri, Hayat, Guillot, Hélène, Bertinchamp, Rémi, Jachiet, Marie, Poirot, Justine, Galicier, Lionel, Oksenhendler, Eric, Boutboul, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175857/
https://www.ncbi.nlm.nih.gov/pubmed/35846183
http://dx.doi.org/10.1002/jha2.353
Descripción
Sumario:Idiopathic multicentric Castleman disease (iMCD) is a lymphoproliferative disease of unknown etiology. Deciphering mechanisms involved in CD pathogenesis may help improving patients’ care. Six cases of stereotyped sub‐diaphragmatic iMCD affecting lower limb‐draining areas and associated with severe and often ulcerative lower extremity chronic dermatological condition were identified in our cohort. Pathological examination revealed mixed or plasma‐cell type MCD. In three patients, shotgun metagenomics failed to identify any pathogen in involved lymph nodes. Antibiotics had a suspensive effect while rituximab and tocilizumab failed to improve the condition. This novel entity requires a specific approach and exclusion of potentially harmful immunomodulation.